BEVERLY, Mass. — seqWell™ announced agreements to bring plexWell™ technology and products for multiplexed NGS applications to global markets, setting up an international distribution network via partnerships covering fifteen (15) countries in Asia-Pacific Rim, Europe and the Middle East. plexWell’s normalizing iterative barcoding library preparation technology affords the creation of balanced multiplexed NGS library pools without the need for […]
We are very pleased to welcome Elta 90 Molecular Medicine (Elta90 MM) as GenDx distributor for North Macedonia. Elta 90 is one of the leading companies in the Balkan peninsula regarding the sale of in vitro diagnostic agents, immunological and microbiological examinations, appliances, laboratory equipment, reagents, diagnostic sets and consumable laboratory materials. For more information […]
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality BOSTON — ABclonal Technology, a new and growing provider of biology research reagents and services, and BenchSci, a life science machine learning company backed by Google’s AI fund, have entered into a partnership to provide […]
Partnership targets broader availability of new models and tools for cancer research CAMBRIDGE, Mass. — Cellaria, LLC, a scientific innovator that develops revolutionary new models for cancer and other diseases, today announced a new distribution partnership with Rockland Immunochemicals, Inc. (Rockland), a life science supplier and manufacturer that specializes in antibodies and antibody-based tools for research applications […]
VICTORIA – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) subcontract from Leidos Biomedical Research, Inc., which currently operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute (NCI). Under the subcontract, IPA will discover and produce rabbit monoclonal antibodies […]
Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s innovative image-driven liquid handling […]
For a few years now, molecular biology has been completely dominated by single cell technologies. It all started with single cell RNA-Seq, but rapidly branched out to other applications, such as epigenomics, regulation (ATAC-Seq and ChIP-Seq), and proteomics (for a high-level overview, we suggest an excellent recent articlein Nature Reviews Genetics). Analysis of single cell data sets […]
New REAlease® Fluorochrome Technology available BERGISCH GLADBACH, February 21, 2019 – The new REAlease® Releasable Antibodies from Miltenyi Biotec are based on the ground-breaking REAlease® Fluorochrome Technology and allow for the removal of antibodies after cell sorting in just one step. Sorted cells are label-free to provide maximal flexibility in downstream applications. Multicolor flow cytometry-based cell sorting is the method of […]
Darrin M Disley, PhD, DSc, OBE, appointed as CEO New investment from Ahren Innovation Capital, 24Haymarket and Dr Disley Mogrify’s technology enables the conversion of any mature cell type into any other mature cell type without going through a pluripotent stem cell- or progenitor cell-state Promises to address the unmet market need for cell types […]
Murrieta Genomics, the genomic sequencing business incubator and SeqOnce, an emerging leader in the rapidly growing NGS (Next Generation Sequencing) field, have announced a partnership to bring fast and simple sample solutions for the Murrieta Genomics laboratory and incubator. “As an innovation center and idea incubator, we are always looking for new applications in the genomic […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
